Khoa Dược - Bệnh viện Đa khoa Đồng Nai

https://khoaduocbvdkdongnai.org


Thông tin an toàn về thuốc SERRAPEPTASE

SERRAPEPTASE có hiệu quả không rõ ràng trong điều trị

SERRAPEPTASE EVALUATION

Description Serrapeptase is also known as serratiopeptidase and Serratia extracellular protein. It is a proteolytic enzyme derived from Serratia spp and has found popular use in some countries to relieve inflammation associated with surgery, trauma or infection, and for  respiratory-tract congestion or chromic venous insufficiency.
It is actively marketed in several countries, including Argentina, Brazil, France, Germany, Greece, India, Italy, Malaysia, Mexico, Portugal, Singapore, Thailand (1) and Vietnam.
Evaluation Several clinical studies have been conducted on serrapeptase but Martindale, a comprehensive drug reference which adheres to evidence-based medicine, in its review considers serrapeptase to be used for its ‘supposed action in relieving inflammation and oedema associated with trauma, , infection, respiratory-tract congestion, or chronic venous insufficiency’ (1). No definitive proof of efficacy has been established for serrapeptase.
Countries with stringent criterion of proof of efficacy for registration have not registered serrapeptase as medicinal product. Such countries include the United States, Canada, Australia and the United Kingdom (2,3,4,5).
References
  1. Martindale. The complete drug reference in www.medicinescomplete.com
  2. US Food and Drug Administration in www.fda.gov
  3. Health Canada in www.hc-gc.ca
  4. Australia Therapeutic Goods Administration in www.tga.gov.au
  5. UK Medicines and Healthcare Products Regulatory Agency in www.mhra.gov.uk 
                                                                                                                                                                                                                                                                                                                               
                                                                                                            Isidro C Sia
                                                                                                            Consultant
                                                                                                            4 January 2005


 

                                                               
                                                                                                

Bạn đã không sử dụng Site, Bấm vào đây để duy trì trạng thái đăng nhập. Thời gian chờ: 60 giây